[DOI] [PMC free article] [PubMed] [Google Scholar] Fu Z, Gilbert ER, Liu D, 2013
Current markers (e.g., GPX4 expression, serum iron, and lipid peroxides) lack specificity for LN, as they are altered in other autoimmune diseases or kidney disorders
HGPRT catalyzes the following two interconversions: hypoxanthine + PRPP IMP + PP i guanine + PRPP GMP + PP i A complete or virtually complete loss of HGPRT activity results in the severe disorder, Lesch-Nyhan syndrome
Since the injectable market centers on the vial, it is worth addressing the vial format directly both what it is and what it is not evidence of
doi:10.1111/j.1471-4159.2010.07109.x
G., Enzmann, H., Pate, I., and Waechter, F